What We Do
Pioneering a new approach to treating complex diseases and supporting health using Endogenous Metabolic Modulators (EMMs).
Endogenous Metabolic Modulators
Endogenous Metabolic Modulators, or EMMs, are a critical set of molecules that are fundamental to biology. They serve as master regulators and signaling agents for metabolic pathways throughout the body. EMMs encompass a broad set of molecular families, including amino acids and their derivatives.
We combine our deep understanding of metabolic pathways, our unique EMM-focused database and recent advances in technology and systems biology to design novel product candidates with the potential to have a profound impact on complex diseases and support health.
Our Therapeutic Pipeline
The clinical data we have generated to date support the potential for our therapeutic product candidates to simultaneously influence multiple biologies relevant to complex diseases with a favorable safety profile. Our lead product candidates are for liver diseases. We also have additional muscle and blood programs in earlier-stage development.